Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

European Multidisciplinary Cancer Conference 2011 (ECCO ESMO ESTRO)

ECCO-ESTRO-ESMO 2011 resources
Start date
23 Sep 2011
End date
27 Sep 2011
Stockholm, Sweden

We are pleased to report that The European Multidisciplinary Cancer Congress was a great success with the participation of almost 16,000 people from 116 countries!

Access EMCC 2011 Webcasts

Video highlights (exclusively by ESMO)

ESMO interviews Alberto Sobrero, MD, PhD about the results of a phase III study of aflibercept versus placebo in combination with Folfiri for the treatment of patients with previously-treated metastatic colorectal cancer (VELOUR).

More videos from EMCC 2011 on ESMO Youtube Channel:
  • Interview with Fabrice André: an independent expert comment on the impact of the ph-III BOLERO-2 study and a perspective on clinical practice consequences for patients with hormone refractory advanced breast cancer
  • Interview with Karim Fizazi:  Radium-223 Chloride proved to be effective in the treatment of patients with symptomatic bone metastases in castration-resistant prostrate cancer
  • Interview with Fortunato Ciardiello: VANTAGE 014 – urgent need to identify new drugs against advanced pleural mesothelioma to face peack of cases in 10 years

If you have any questions about webcasts, certificates of attendance or poster certificates, abstracts, press releases, etc., please contact the European Cancer Organisation (ECCO)

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.